Literature DB >> 9605236

Results of transsphenoidal hypophysectomy in 52 dogs with pituitary-dependent hyperadrenocorticism.

B P Meij1, G Voorhout, T S van den Ingh, H A Hazewinkel, E Teske, A Rijnberk.   

Abstract

OBJECTIVE: To evaluate microsurgical transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism (PDH). STUDY
DESIGN: Prospective study to evaluate the results (survival and disease-free interval, remission, recurrence) and complications of microsurgical transsphenoidal hypophysectomy by clinical follow-up, computed tomography (CT), and urinary corticoid-to-creatinine (C/C) ratios in dogs with PDH. The effect of surgical experience was investigated by comparing results of hypophysectomy cases 1 through 26 and 27 through 52. ANIMALS OR SAMPLE POPULATION: 52 dogs with PDH.
RESULTS: Preoperative CT enabled accurate assessment of pituitary size (24 nonenlarged and 28 enlarged) and localization relative to intraoperative anatomic landmarks. Treatment failures included procedure-related mortalities (five dogs) and incomplete hypophysectomies (four dogs). The 1-year estimated survival rate was 84% (95% confidence interval [CI], 71% to 92%). The 2-year estimated survival rate was 80% (95% CI, 65% to 90%). In 43 dogs, the hyperadrenocorticism went into remission. Hyperadrenocorticism recurred in five dogs. The 1-year estimated relapse-free fraction was 92% (95% CI, 76% to 97%). The main complications were transient, mild, postoperative hypernatremia; transient reduction or cessation of tear production (25 eyes in 18 dogs); permanent (five dogs) or prolonged (nine dogs) diabetes insipidus; and secondary hypothyroidism. Normal tear production had resumed in all but one case after a median period of 10 weeks. In the second case series (27 through 52), the hospitalization period was shorter, the number of dry eyes fewer, the survival fraction greater, and the postoperative mortality lower than in the first series. In 15 dogs in which remission was obtained, postoperative CT images suggested the presence of small pituitary remnants; in 1 of these, hyperadrenocorticism recurred. In 46 dogs, the histological diagnosis was pituitary adenoma.
CONCLUSIONS: Microsurgical transsphenoidal hypophysectomy in dogs with PDH is an effective method of treatment in specialized veterinary institutions having access to advanced pituitary imaging techniques. Postoperative CT findings do not correlate well with remission or subsequent recurrence of hyperadrenocorticism. CLINICAL RELEVANCE: The neurosurgeon performing hypophysectomies must master a learning curve and must be familiar with the most frequent complications of the operation to recognize them as early as possible and to treat them immediately and effectively. Urinary C/C ratios are sensitive indicators for the assessment of remission and recurrence of hyperadrenocorticism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605236     DOI: 10.1111/j.1532-950x.1998.tb00123.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  15 in total

1.  A 3-Dimensional Printed Patient-Specific Surgical Guide to Facilitate Transsphenoidal Hypophysectomy in Dogs.

Authors:  Leticia Escauriaza; Joe Fenn; John McCue; Darren Roper; Helene Vandenberghe; George Nye; Bill Oxley; Nicolas Granger
Journal:  Front Vet Sci       Date:  2022-06-20

2.  Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease.

Authors:  C de Bruin; J M Hanson; B P Meij; H S Kooistra; A M Waaijers; P Uitterlinden; S W J Lamberts; L J Hofland
Journal:  Endocrinology       Date:  2008-05-15       Impact factor: 4.736

3.  Effects of radiotherapy on pituitary corticotroph macrotumors in dogs: a retrospective study of 12 cases.

Authors:  Pauline de Fornel; Françoise Delisle; Patrick Devauchelle; Dan Rosenberg
Journal:  Can Vet J       Date:  2007-05       Impact factor: 1.008

4.  The prognostic value of perioperative profiles of ACTH and cortisol for recurrence after transsphenoidal hypophysectomy in dogs with corticotroph adenomas.

Authors:  S J van Rijn; J M Hanson; D Zierikzee; H S Kooistra; L C Penning; M A Tryfonidou; B P Meij
Journal:  J Vet Intern Med       Date:  2015-05-08       Impact factor: 3.333

5.  Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas.

Authors:  Silviu Sbiera; Marianna A Tryfonidou; Isabel Weigand; Guy C M Grinwis; Bart Broeckx; Sabine Herterich; Bruno Allolio; Timo Deutschbein; Martin Fassnacht; Björn P Meij
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

6.  Biological Variability in Serum Cortisol Concentration Post-adrenocorticotropic Hormone Stimulation in Healthy Dogs.

Authors:  A Gal; K Weidgraaf; J P Bowden; N Lopez-Villalobos; N J Cave; J P Chambers; F Castillo-Alcala
Journal:  J Vet Intern Med       Date:  2017-04-13       Impact factor: 3.333

7.  Restored vision in a young dog following corticosteroid treatment of presumptive hypophysitis.

Authors:  Nina Marie Rzechorzek; Tiziana Liuti; Catherine Stalin; Katia Marioni-Henry
Journal:  BMC Vet Res       Date:  2017-02-28       Impact factor: 2.741

8.  Concurrent pituitary and adrenocortical lesions on computed tomography imaging in dogs with spontaneous hypercortisolism.

Authors:  Kirsten L van Bokhorst; Hans S Kooistra; Susanne A E B Boroffka; Sara Galac
Journal:  J Vet Intern Med       Date:  2018-12-11       Impact factor: 3.333

9.  Apoptosis of supraoptic AVP neurons is involved in the development of central diabetes insipidus after hypophysectomy in rats.

Authors:  Yihua Wang; Cuiping Zhao; Zhigang Wang; Chengwei Wang; Wenfeng Feng; Lijin Huang; Jialin Zhang; Songtao Qi
Journal:  BMC Neurosci       Date:  2008-06-25       Impact factor: 3.288

10.  The Influence of Pituitary Size on Outcome After Transsphenoidal Hypophysectomy in a Large Cohort of Dogs with Pituitary-Dependent Hypercortisolism.

Authors:  S J van Rijn; S Galac; M A Tryfonidou; J W Hesselink; L C Penning; H S Kooistra; B P Meij
Journal:  J Vet Intern Med       Date:  2016-07-18       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.